Literature DB >> 21228544

Patterns of inflammatory responses in large and small airways in smokers with and without chronic obstructive pulmonary disease.

Sergejs Isajevs1, Immanuels Taivans, Darja Svirina, Gunta Strazda, Uldis Kopeika.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterised by progressive and irreversible airway obstruction. Smoking causes persistent inflammation in lung tissue. However, differences in inflammatory responses between the large and small airways have not been systematically explored among smokers with and without COPD.
OBJECTIVES: The aim of our research was to characterise the expression and localisation of NF-κBp65 and histone deacetylase 2 (HDAC2) as well as inflammatory cell (macrophages, lymphocytes, neutrophils) distribution in large and small airways, in nonsmokers and in smokers with and without COPD.
METHODS: Nineteen nonsmokers, 20 smokers with normal lung ventilation function and 20 smokers with moderate COPD, undergoing lung resection for a solitary peripheral carcinoma, were enrolled in the study. Immunohistochemical methods were used to evaluate NF-κBp65 and HDAC2 expression and identify inflammatory cells in airways.
RESULTS: COPD patients had increased NF-κBp65 expression compared to nonsmokers and smokers without COPD, in both large and small airways, which corresponded to increased numbers of macrophages, CD8+ T lymphocytes and neutrophils. COPD patients had more macrophages in large compared to small airways and more CD8+ T lymphocytes and neutrophils in small compared to large airways. HDAC2 expression was significantly downregulated in smokers with COPD in small compared to large airways.
CONCLUSIONS: Our findings indicate a nonuniform distribution of inflammatory cells throughout the bronchial tree. However, in both smokers with and without COPD, similar patterns of inflammatory processes occur in both large and small airways. The difference between smokers with and without COPD is only quantitative.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228544     DOI: 10.1159/000322560

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  12 in total

1.  Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects.

Authors:  Raminder Aul; Jane Armstrong; Annelyse Duvoix; David Lomas; Brian Hayes; Bruce E Miller; Chris Jagger; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

2.  Transcriptional suppression of CYP2A13 expression by lipopolysaccharide in cultured human lung cells and the lungs of a CYP2A13-humanized mouse model.

Authors:  Hong Wu; Zhihua Liu; Guoyu Ling; David Lawrence; Xinxin Ding
Journal:  Toxicol Sci       Date:  2013-07-24       Impact factor: 4.849

3.  COPD-dependent effects of genetic variation in key inflammation pathway genes on lung cancer risk.

Authors:  Donovan Watza; Christine M Lusk; Gregory Dyson; Kristen S Purrington; Angela S Wenzlaff; Christine Neslund-Dudas; Ayman O Soubani; Shirish M Gadgeel; Ann G Schwartz
Journal:  Int J Cancer       Date:  2019-12-12       Impact factor: 7.396

4.  Not all measures of hyperinflation are created equal: lung structure and clinical correlates of gas trapping and hyperexpansion in COPD: the Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study.

Authors:  Benjamin M Smith; Eric A Hoffman; Robert C Basner; Steven M Kawut; Ravi Kalhan; R Graham Barr
Journal:  Chest       Date:  2014-06       Impact factor: 9.410

5.  Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency.

Authors:  Marion Bouchecareilh; Darren M Hutt; Patricia Szajner; Terence R Flotte; William E Balch
Journal:  J Biol Chem       Date:  2012-09-20       Impact factor: 5.157

6.  Macrophages of M1 phenotype have properties that influence lung cancer cell progression.

Authors:  Alexander Hedbrant; Jonny Wijkander; Tomas Seidal; Dick Delbro; Ann Erlandsson
Journal:  Tumour Biol       Date:  2015-06-07

7.  Chronic NF-κB activation links COPD and lung cancer through generation of an immunosuppressive microenvironment in the lungs.

Authors:  Rinat Zaynagetdinov; Taylor P Sherrill; Linda A Gleaves; Pierre Hunt; Wei Han; Allyson G McLoed; Jamie A Saxon; Harikrishna Tanjore; Peter M Gulleman; Lisa R Young; Timothy S Blackwell
Journal:  Oncotarget       Date:  2016-02-02

Review 8.  Are healthy smokers really healthy?

Authors:  Zijing Zhou; Ping Chen; Hong Peng
Journal:  Tob Induc Dis       Date:  2016-11-15       Impact factor: 2.600

9.  Reproducibility and respiratory function correlates of exhaled breath fingerprint in chronic obstructive pulmonary disease.

Authors:  Raffaele Antonelli Incalzi; Giorgio Pennazza; Simone Scarlata; Marco Santonico; Massimo Petriaggi; Domenica Chiurco; Claudio Pedone; Arnaldo D'Amico
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  Nuclear factor-kappa B influences early phase of compensatory lung growth after pneumonectomy in mice.

Authors:  Yusuke Takahashi; Noriyuki Matsutani; Hitoshi Dejima; Takashi Nakayama; Hirofumi Uehara; Masafumi Kawamura
Journal:  J Biomed Sci       Date:  2017-07-05       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.